13 11 20

Information and support

  • Get informed
  • Get support
  • Cut my risk
  • Get involved
  • Research
  • AMG 510 (BM)

    Acronym: 

    AMG 510 (BM)

    ACTRN/NCT /ethics: 

    Scientific title: 

    A Non-Interventional Biomarker Study on the Molecular Evaluation of Archival Tumor Tissue in Subjects with Non-Small Cell Lung Cancer (NSCLC)

    Summary of trial and patient characteristics

    Cancer Type Lung & mesothelioma
    Trial Type Early detection, diagnosis, prognosis
    Phase All phases Tumour Stream NSCLC
    Age Range 18 years and older Cancer Stage All stages
    Sex Both Anticipated Start Date
    Molecular Target Anticipated End Date
    Cancer Type Lung & mesothelioma
    Trial Type Early detection, diagnosis, prognosis
    Phase All phases
    Age Range 18 years and older
    Sex Both
    Molecular Target
    Tumour Stream NSCLC
    Cancer Stage All stages
    Anticipated Start Date
    Anticipated End Date

    Trial Summary

    A Non-Interventional Biomarker Study on the Molecular Evaluation of Archival Tumor Tissue in Subjects with Non-Small Cell Lung Cancer (NSCLC)

    Lay Summary

    A Non-Interventional Biomarker Study on the Molecular Evaluation of Archival Tumor Tissue in Subjects with Non-Small Cell Lung Cancer (NSCLC)

    Sponsor / Cooperative group

    Participating Hospitals

    Hospital Clinical Trial Coordinator Email Phone Principal Investigator Recruitment Status
    The Queen Elizabeth Hospital Pamela Cooper pamela.cooper@sa.gov.au 08 8222 6410 Dr Rachel Roberts-Thomson Not Yet Recruiting